PTP (TN01)

Pathway to Prevention
1. To identify family members of people with type 1 diabetes that may be at risk for developing type 1 diabetes. 2. To monitor the metabolic and immunologic status of at-risk individuals. Eligible individuals will be offered enrollment in type 1 diabetes prevention studies. See website for more details https://www.trialnet.org/
CHLA IRB Number
CHLA-17-00507
Study Type
Observational
Eligibility
1. Be between 2.5 to 45 years and a sibling, offspring, or parent of an individual with type 1 diabetes. 2. Be between 2.5 to 20 years and a niece, nephew, aunt, uncle, grandchild, cousin, or half sibling of an individual with type 1 diabetes. 3. Those who are not family members and are known to have 1 or more islet antibodies are eligible for screening if needed to determine eligibility for a clinical trial to delay or prevent disease progression.
Clinical Trials Government Identifier
NCT00097292
Enrollment Status
Open
Does this study also recruit healthy volunteers?
No
Coordinator Contact
Debra Miller
Contact Email
dmiller@chla.usc.edu